Three years later this Benicar (olmesartan) FDA safety review is still ongoing. Benicar -- as well as Benicar HCT, Azor, and Tribenzor -- is an angiotensin II receptor blocker (ARB) used as a blood pressure medication. The drug company Daiichi Sankyo makes Benicar. This safety review update is in follow-up to the FDA Drug Safety Communication: Ongoing Safety Review of Benicar (olmesartan) and cardiovascular events on 6/11/2010.